Taken together, dual inhibition of the MAPK pathway with the panRAF inhibitor brimarafenib and the MEK inhibitor mirdametinib reduces phosphorylation of MEK and ERK and effectively induces apoptosis in melanoma cells. The gene discussed is MAP2K7; the disease is melanoma.